Atypical chronic myeloid leukemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Mar 2026Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia

Jonsson Comprehensive Cancer Center — PHASE2

TrialNOT YET RECRUITING
May 2025Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

St. Petersburg State Pavlov Medical University — PHASE2

TrialRECRUITING
Aug 2024Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

Uma Borate — PHASE1, PHASE2

TrialRECRUITING
Apr 2023Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Mayo Clinic — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Atypical chronic myeloid leukemia.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
1Phase 2
1Phase 1
1PHASE1, PHASE2
3Total recruiting
Search clinical trials for Atypical chronic myeloid leukemia

Recent News & Research

No recent news articles indexed yet for Atypical chronic myeloid leukemia.
Search PubMed for Atypical chronic myeloid leukemia

Browse all Atypical chronic myeloid leukemia news →

Specialist Network

Top 6 by expertise

View all Atypical chronic myeloid leukemia specialists →

Quick Actions